QbD Group Acquires EUDRAC Ltd., Expanding Regulatory Affairs and Pharmacovigilance Services for Pharmaceutical Clients
- Home
- News & Events
- QbD Group Acquires EUDRAC Ltd., Expanding Regulatory Affairs and Pharmacovigilance Services for Pharmaceutical Clients
QbD Group Acquires EUDRAC Ltd., Expanding Regulatory Affairs and Pharmacovigilance Services for Pharmaceutical Clients
Tuesday, 08 November 2022
QbD Group
Share
\
\
X (Twitter) 
\
\
LinkedIn 
\
\
WhatsApp 
\
\
Copy link 
\
\
Mail
QbD Group announced the acquisition of EUDRAC Ltd., a specialist regulatory and pharmacovigilance consultancy. Read the full press release here.
.png?width=900&height=541&name=QbD%20Group%20Acquires%20EUDRAC%20Ltd.%2c%20Expanding%20Regulatory%20Affairs%20and%20Pharmacovigilance%20Services%20for%20Pharmaceutical%20Clients%20(1).png)
Wilrijk, Belgium & Oxfordshire, UK, November 8, 2022 – The QbD Group, a privately held company offering comprehensive support to life science companies throughout the entire product lifecycle, today announced the acquisition of EUDRAC Ltd., a specialist regulatory and pharmacovigilance consultancy.
EUDRAC Ltd. provides a bespoke consultancy service throughout product development, regulatory approval, market launch, and into life cycle management. Their success is built upon strong relationships with EMA and MHRA and experience across a wide range of therapeutic areas, pharmaceutical forms, and in-depth knowledge of legislation and guidance.
Joining the QbD Group will allow EUDRAC Ltd. access to a broader client base and the infrastructure necessary to ensure continued growth. EUDRAC Ltd. will be renamed QbD Ltd.
In turn, this acquisition will expand the QbD Group’s regulatory affairs division to better serve its pharmaceutical customers, including those developing advanced therapy medicinal products (ATMPs).
We’re delighted to bring our expertise into the QbD group. This is the right time for us to make this step and will allow us to benefit from the synergies the acquisition will bring. In addition to bringing opportunities for business growth, it will give our team of experts opportunities to broaden their knowledge and skills.
Carole Pugh
Managing Director of EUDRAC Ltd.
QbD Group is continuously expanding our already broad ecosystem through strategic alliances and acquisitions. The addition of EUDRAC Ltd. takes us yet another step closer to our QbDream of offering a comprehensive range of skills and expertise to support product development throughout the life sciences.”
Bart Van Acker
founder and CEO of QbD Group
About EUDRAC Ltd.
EUDRAC Ltd. is a specialized regulatory affairs and pharmacovigilance consultancy company, focussed on EU and UK requirements. Core activities include guidance through orphan and pediatric procedures, clinical trial support, scientific advice, labeling (including linguistic review), and management of marketing authorization applications (MAA). Their client basis extends to companies based in the EU, US, Switzerland, Israel, and the UK.
About the QbD Group
Since 2011, QbD has been providing quality solutions for product development and manufacturing. The QbD Group’s team offers the skills and expertise for solving complex problems for companies active in the life sciences. The QbD Group is headquartered in Belgium and has over 500 consultants worldwide in the Netherlands, Spain, France, the UK, Switzerland, Mexico, Colombia, and the US. For more information about the QbD Group, visit https://qbdgroup.com
QbD Group offers life science companies a range of services from idea to patient within seven divisions:
- Regulatory Affairs: We help our clients in their journey throughout the entire drug and medical device regulatory lifecycle.
- Clinical: We are an expert clinical solutions provider specialized in medical devices and biotech, offering global CRO services and consultancy.
- Qualification and Validation: We guarantee that products meet quality demands and comply with regulations through the qualification and validation of your equipment, facilities, and process support.
- Quality Assurance: We offer the full range of QA services necessary to get your product to market in a safe and compliant way, including auditing from certified auditors, setting up your QMS, and all QP (Qualified Person) activities.
- Lab Services: Our QC division consists of a GMP laboratory that offers analytical services for testing pharmaceutical raw materials, excipients, and release testing of finished products.
- Software Solutions & Services: Our solutions include a cloud-based and pre-validated QMS built for the life sciences, as well as eIFU services which enable IVD and MD manufacturers to digitalize paper Instructions For Use. Our range of services includes Computer System Validation and Digital Health services.
- Business & Communications: We offer marketing and communication services to all life science clients and strategic, tailor-made services for commercialization.
Regulatory Affairs
Want to know how QbD Group
can help you with regulatory services?
More latest news
Previous
31 May 2024
QbD Group Once Again Awarded Gold Label as Best Managed Company
QbD Group was reaffirmed as a Gold laureate in the Best Managed Companies program. The Best Managed...
23 May 2025
QbD Group awarded Gold Label as Best Managed Company 2025
We’re proud to share that QbD Group has once again been recognized as one of Belgium’s Best Managed...
12 May 2023
QbD Group awarded Deloitte’s Best Managed Company Gold Label
The Best Managed Companies program assesses participants annually based on a well-established...
1 Jan 2021
QbD Group and Inovigate Collaborate to Launch Health to Market: A New Contract Commercialization Organization in Life Sciences
QbD Group has added yet another important link in the chain that provides clients with a solid...
19 Oct 2022
Qarad's eIFU Services Rebrand as 'IFUcare'
Qarad - part of the QbD Group - announced the rebranding of its existing eIFU services to their new...
31 May 2024
QbD Group Once Again Awarded Gold Label as Best Managed Company
QbD Group was reaffirmed as a Gold laureate in the Best Managed Companies program. The Best Managed...
23 May 2025
QbD Group awarded Gold Label as Best Managed Company 2025
We’re proud to share that QbD Group has once again been recognized as one of Belgium’s Best Managed...
12 May 2023
QbD Group awarded Deloitte’s Best Managed Company Gold Label
The Best Managed Companies program assesses participants annually based on a well-established...
1 Jan 2021
QbD Group and Inovigate Collaborate to Launch Health to Market: A New Contract Commercialization Organization in Life Sciences
QbD Group has added yet another important link in the chain that provides clients with a solid...
19 Oct 2022
Qarad's eIFU Services Rebrand as 'IFUcare'
Qarad - part of the QbD Group - announced the rebranding of its existing eIFU services to their new...
31 May 2024
QbD Group Once Again Awarded Gold Label as Best Managed Company
QbD Group was reaffirmed as a Gold laureate in the Best Managed Companies program. The Best Managed...
23 May 2025
QbD Group awarded Gold Label as Best Managed Company 2025
We’re proud to share that QbD Group has once again been recognized as one of Belgium’s Best Managed...
Next
- 1
- 2
- 3
Stay ahead in life sciences
Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.
Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.
Twitter Widget Iframe